About Matthew Jenusaitis

Matthew Jenusaitis

Matthew Jenusaitis, President & CEO, OCTANe

Matthew Jenusaitis is the President and CEO of OCTANe, an Orange County, CA non-profit organization focused on catalyzing innovation, starting new medical and high technology companies, and creating jobs.  Matthew is an experienced medical device industry professional with more than 25 years of engineering, sales and marketing, and executive level general management experience.

Before OCTANe, Mr. Jenusaitis worked with the venture backed accelerator fund, ConcepTx, identifying unmet clinical opportunities and developing new technologies and companies.  Prior to ConcepTx, Matthew was and executive in residence for the private equity firm Warburg Pincus, LLC.  This led to Matthew assuming the role of President of ev3 Neurovasuclar, one of Warburg’s portfolio companies.  Matthew led their growing division (formerly MicroTherapeutics Inc., now a wholly-owned company subsidiary) through a combination of organizational development activities, and by launching and developing markets for a number of new products, including the AxiumÒ Embolization Coil and the Onyx® Liquid Embolic System.

Prior to ev3, Matthew spent 15 years at Boston Scientific Corp., where he served in numerous executive marketing and general management positions. His most recent position with Boston Scientific was as the president of the $600 Million Peripheral Interventions Division (formerly Medi-Tech) leading the acquisition and integration of Cryovascular Systems, Inc. and EndoTex, Inc..  Prior to Peripheral Interventions, Matthew led the integration of Interventional Technologies increasing their annual revenues from $25 Million in 2001 to more than $150 Million in 2003.  Before that, he held executive marketing and marketing management positions in the Microvasive Endoscopy, International, and Scimed Life Sciences division.

During his career, Matthew also spent 8 years at Baxter healthcare in both marketing and engineering management positions.

Jenusaitis holds a bachelor of science in chemical engineering cum laude from Cornell University, a master of science in bio-chemical engineering from Arizona State University and a master of business administration from University of California, Irvine.